The genetic stability of attenuated Human immunodeficiency virus 1 (HIV-1) variants harbouring mutations (Gly or Lys) of Asn17, the protease-cleavage site of the proximal zinc finger of the nucleocapsid protein, was studied. All possible codons for the Gly mutants were tested as starting sequences. Long-term replication assays revealed that the mutants were unstable; mutations of Gly17 to Arg, Ala, Ser and Cys, as well as a Lys17Asn reversion, were observed. Replication kinetic assays in H9 cells revealed that the replication of Ala, Ser and Arg mutants was improved substantially compared with the Gly variant; the infectivity of Ala17 and Ser17 viruses was equal to, and that of Arg17 was almost equal to, the infectivity of the wild-type virus. Kinetic analysis of the cleavage of oligopeptides representing the corresponding nucleocapsid-cleavage sites revealed that all mutations improved cleavability, in good agreement with the previously proposed role of nucleocapsid cleavage in HIV-1 replication.
AmarasingheG. K.,
De GuzmanR. N.,
TurnerR. B.,
ChancellorK. J.,
WuZ. R.,
SummersM. F.2000; NMR structure of the HIV-1 nucleocapsid protein bound to stem–loop SL2 of the Ψ-RNA packaging signal. Implications for genome recognition. J Mol Biol 301:491–511[CrossRef]
BampiC.,
JacquenetS.,
LenerD.,
DécimoD.,
DarlixJ.-L.2004; The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance. Int J Biochem Cell Biol 36:1668–1686[CrossRef]
De GuzmanR. N.,
WuZ. R.,
StallingC. C.,
PappalardoL.,
BorerP. N.,
SummersM. F.1998; Structure of the HIV-1 nucleocapsid protein bound to the SL3 Ψ-RNA recognition element. Science 279:384–388[CrossRef]
DorfmanT.,
LubanJ.,
GoffS. P.,
HaseltineW. A.,
GöttlingerH. G.1993; Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J Virol 67:6159–6169
HsuM.,
WainbergM. A.2000; Interactions between human immunodeficiency virus type 1 reverse transcriptase, tRNA primer, and nucleocapsid protein during reverse transcription. J Hum Virol 3:16–26
JacobsenH.,
Ahlborn-LaakeL.,
GugelR.,
MousJ.1992; Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease. J Virol 66:5087–5091
KaplanA. H.,
ManchesterM.,
SmithT.,
YangY. L.,
SwanstromR.1996; Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication. J Virol 70:5840–5844
MartínezM. A.,
SalaM.,
VartanianJ.-P.,
Wain-HobsonS.1995; Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction. Nucleic Acids Res 23:2573–2578[CrossRef]
NagyK.,
YoungM.,
BaboonianC.,
MersonJ.,
WhittleP.,
OroszlanS.1994; Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase. J Virol 68:757–765
PantherL. A.,
CoombsR. W.,
AungS. A.,
dela RosaC.,
GretchD.,
CoreyL.1999; Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro. J Med Virol 58:165–173[CrossRef]
PopovicM.,
SarngadharanM. G.,
ReadE.,
GalloR. C.1984; Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500[CrossRef]
RobertsM. M.,
OroszlanS.1989; The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. Biochem Biophys Res Commun 160:486–494[CrossRef]
RobertsM. M.,
OroszlanS.1990; The action of retroviral protease in various phases of virus replication. In Retroviral Proteases: Control of Maturation and Morphogenesis pp 131–139 Edited by
PearlL. H.
London: Macmillan Press;
RobertsM. M.,
CopelandT. D.,
OroszlanS.1991a; In situ processing of a retroviral nucleocapsid protein by the viral proteinase. Protein Eng 4:695–700[CrossRef]
RobertsM. M.,
VolkerE.,
CopelandT. D.,
NagashimaK.,
CassellM. B.,
BriggsC. J.,
OroszlanS.1991b; Regulated proteolytic processing within mature retroviral capsids. In Advances in Molecular Biology and Targeted Treatment for AIDS pp 273–280 Edited by
KumarA.
New York: Plenum;
TözsérJ.,
FriedmanD.,
WeberI. T.,
BlahaI.,
OroszlanS.1993; Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates. Biochemistry 32:3347–3353[CrossRef]
TözsérJ.,
ShuleninS.,
LouisJ. M.,
CopelandT. D.,
OroszlanS.2004; In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence. Biochemistry 43:4304–4312[CrossRef]
UchidaH.,
MaedaY.,
MitsuyaH.1997; HIV-1 protease does not play a critical role in the early stages of HIV-1 infection. Antiviral Res 36:107–113[CrossRef]
VartanianJ.-P.,
MeyerhansA.,
ÅsjöB.,
Wain-HobsonS.1991; Selection, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J Virol 65:1779–1788
VenaudS.,
YahiN.,
FehrentzJ. L.,
GuettariN.,
NisatoD.,
HirschI.,
ChermannJ. C.1992; Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication. Res Virol 143:311–319[CrossRef]